Join to View Full Profile
1500 E Medical Center Dr1ST floor Taubman Center Recp GAnn Arbor, MI 48109
Phone+1 800-333-9013
Dr. Brady is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MichiganFellowship, Gastroenterology, 2013 - 2017- University of MichiganResidency, Internal Medicine, 2011 - 2013
University of Michigan Medical SchoolClass of 2011
Certifications & Licensure
MI State Medical License 2017 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- R644C associates with hepatic steatosis in a large cohort and increases cellular lipid droplet accumulation.Kapil K Upadhyay, Xiaomeng Du, Yanhua Chen, Elizabeth K Speliotes, Graham F Brady
Medrxiv. 2023-12-22 - 3 citationsA common variant that alters SUN1 degradation associates with hepatic steatosis and metabolic traits in multiple cohorts.Kapil K Upadhyay, Xiaomeng Du, Yanhua Chen, Brandon Buscher, Vincent L Chen
Journal of Hepatology. 2023-11-01 - 2 citationsHepatocyte-specific loss of LAP2α protects against diet-induced hepatic steatosis, steatohepatitis, and fibrosis in male mice.Kapil K Upadhyay, Eun-Young K Choi, Roland Foisner, M Bishr Omary, Graham F Brady
American Journal of Physiology. Gastrointestinal and Liver Physiology. 2023-08-01
Press Mentions
Highlights from DDWJuly 22nd, 2022- Let Parents Decide on Covid Jab for 12- to 15-Year-Olds, Say Vaccine AdvisersSeptember 4th, 2021
- Leaked Hospital Numbers from the UK Reveal DiscrepanciesAugust 7th, 2021
- Join now to see all
Grant Support
- Role of SUN1 in MASLD and metabolic diseaseUNIVERSITY OF MICHIGAN AT ANN ARBOR2024–2026
- Nuclear lamins and the hepatocyte nuclear envelope in nonalcoholic fatty liver diseaseUNIVERSITY OF MICHIGAN AT ANN ARBOR2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
